Clarifi logo with tagline Strategy That Speaks Regulation, representing Clarifi Strategy, the investor and startup advisory division of Clarifi Oy.

Clarifi Policy & Advocacy - Part of the Clarifi Group

Turning Regulatory Insight Into Public Good.

Clarifi Policy & Advocacy supports NGOs, journalists, policymakers, and victims of regulatory failures in turning evidence into change, accountability, and safer public systems.

Part of the Clarifi Group

From Evidence To Impact

We translate complex regulatory and technical data into actionable insights for advocacy, governance, and reform.Our work includes:- Drafting policy briefs and consultation responses
- Regulatory analysis for investigative journalism
- Patient-safety and NGO support in transparency campaigns
- Legislative and EU-policy monitoring for reform initiativesWe bridge the gap between compliance language and civic accountability.

Minimal vector illustration of a business strategy plan and data charts symbolising Clarifi Strategy’s regulatory and growth planning services.

CLARIFI.FI

Track Record

- PIP Implant Scandal Survivors: Provided technical and regulatory input supporting litigation and advocacy for safer medical-device oversight.- Movendi International: Authored policy commentary on alcohol regulation and corporate accountability in public health.- Spina Bifida & Hydrocephalus Advocacy Group (Ireland): Conducted regulatory review of leaked hospital governance reports to aid systemic reform.- European Parliament Candidacy (Dublin, 2024): Founder Stephen O’Rourke ran as an independent candidate on evidence-based policy, mental-health advocacy, and political reform.

Vector illustration of founders presenting Clarifi Policy & Advocacy teamwork collaboration

CLARIFI.FI

Why Clarifi

Clarifi brings the analytical depth of regulatory affairs to the public-interest space.
We combine real-world technical understanding with policy literacy — helping reformers argue for change with precision and credibility.Integrity, independence, and impact — that’s the Clarifi approach to advocacy.

Illustration showing magnifying glass over documents and graphs, symbolising Clarifi Strategy’s regulatory due-diligence services for venture capital firms and accelerators.

CLARIFI.FI

Who It's For

- NGOs & patient organisations
- Investigative journalists & public-interest law firms
- Policymakers (including MEPs and their staff) & regulators seeking independent expertise
- Research institutes & think tanks

Portrait of Stephen O’Rourke, founder of Clarifi Oy and lead strategist for Clarifi Strategy, specialist in regulatory affairs and investment readiness.

How We Collaborate

- Expert input for campaigns and submissions
- Regulatory analysis or expert-witness statements
- Co-authored white papers and policy briefs
- Speaking engagements, workshops, and panelsIf your work touches policy, health, or ethics, we can help you turn evidence into meaningful change.Get in touch below or at info(at)clarifi.fi

Clarifi in the Media

Insights and features on how regulation, innovation, and startup strategy intersect — from MedTech to FoodTech and beyond.Startups don’t just need tech leads: They need an integrator.
Feature for EU-Startups
Read →Confidential by Default? The Transparency Dilemma in Europe’s Novel Foods System.
Feature for Green Queen Media
Read →From Gatekeeping to Guiding: The Case for Collaborative Regulation in Mission-Driven Innovation
White Paper in Collaboration with GCI
Read →Digital Health Meets Red Tape: What Pharma Can Learn from Software as a Medical Device
The role of SaMD in pharma covering regulations, AI/ML risks, compliance, and digital health strategies.
Feature for PharmaNow
Read →Lessons from a €50 million Series B: And why it matters at every startup funding stage
Feature for EU-Startups
Read →What does Gourmey’s regulatory milestone mean for cell-cultivated meat?
Interviewed by FI Global Insights
Read →Why EU Innovators Face Growing Barriers With EU Combination Product Regulation
Interviewed by Medtech Insight
Read →From WHOOP to DiGA: Where the Wellness Line Becomes a Regulatory Minefield
Feature for Test Labs UK Outlook
Read →Guest article: EU novel food delays. Why bureaucracy is choking off food innovation
Feature for AgFunder News
Read →How AI can get your novel food approved faster
Interviewed by FoodNavigator Europe
Read →Apple vs WHOOP: Two Blood Pressure Strategies, Two Very Different Regulatory Journeys
Feature for Test Labs UK Outlook
Read →For interviews, collaborations, or speaking opportunities, contact info(at)clarifi.fi

Clarifi Policy & Advocacy is part of Clarifi Oy

© 2025 Clarifi OyPart of Clarifi Oy — Regulatory | Strategy | Marketing | Ghostwriting | Grants | Policy & Advocacy | Communication | Career CoachingHelsinki, Finland / Suomi | Y-tunnus 3565244-7This website does not use cookies or analytics tracking.